FDA Urges Accurate Dosage of Moderna COVID-19 Vaccine for Children
The FDA has become aware that some providers may not realize the Moderna COVID-19 vaccine vial for ages 6 months to 11 years holds more than the 0.25 mL dose.
The FDA has become aware that some providers may not realize the Moderna COVID-19 vaccine vial for ages 6 months to 11 years holds more than the 0.25 mL dose.
The FDA has authorized bivalent COVID-19 vaccines from Moderna and Pfizer-BioNTech as a single booster dose in younger age groups, according to the agency.
A 50 µg dose of Moderna's bivalent booster candidate, mRNA-1273.214, demonstrated superior neutralizing antibody response against the Omicron variant one month after administration when compared to the original mRNA-1273 vaccine.
The FDA expanded emergency use for both the Moderna and Pfizer-BioNTech COVID-19 vaccine boosters for all individuals 18 years of age and older.
Read MoreThe FDA authorized single booster doses for the Moderna Inc and Janssen COVID-19 vaccines for certain adults age 18 and older, as well as the use of “mix and match” boosters of differing vaccines.
Read MoreThe FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend emergency use authorization for a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level.
Read MoreModerna’s COVID-19 vaccine booster (mRNA-1273 50µg dose level) induced robust antibody responses of more than 40 times against the Delta variant (B.1.617.2), according to Phase 2 clinical data reported by the company.
Read MoreThe FDA has granted Fast Track designation to Moderna’s investigational single-dose mRNA-1345 vaccine against the respiratory syncytial virus (RSV) for people over 60 years of age.
Read MoreAn immunologist writes about the effectiveness of a single COVID vaccine dose.
Read MoreWest Virginia raced ahead of the country last winter to get people in nursing homes vaccinated against covid-19, but with cases and hospitalizations on the rise again, state officials want to know whether immunity levels are falling for residents who had their shots.
Read MoreThe FDA has requested that vaccine companies expand their trials in several thousand children before seeking emergency authorization.
Read MoreThe FDA has reported increased risks of myocarditis and pericarditis following vaccination with the Moderna and Pfizer-BioNTech COVID-19 vaccine.
Read MoreThe Biden Administration will ship 2 million doses of the Pfizer/BioNTech COVID-19 vaccine to Peru and 2.5 million doses of the Moderna vaccine to Pakistan.
Read MoreThe US government has purchased an additional 200 million doses of Moderna’s COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Moderna’s pipeline.
Read MoreModerna Inc has requested an emergency use authorization for its COVID-19 vaccine in adolescents age 12 to 17 with the FDA. The vaccine has been authorized for adults age 18 and older since December 2020.
Read More